Integrin inhibitor, TCS2314, Purity ≥98%

Cat. No.: X24-08-YM297

Integrin inhibitor, TCS2314, Purity ≥98%

Synonym: 317353-73-4; TCS 2314; TCS-2314; 2-[1-[(3S)-4-[2-[4-[(2-Methylphenyl)carbamoylamino]phenyl]acetyl]morpholine-3-carbonyl]piperidin-4-yl]acetic acid

  • CAS Number: 317353-73-4
  • Compound CID: 11226207
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
TCS2314 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Weight
522.6
Molecular Formula
C28H34N4O6
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
TCS2314 is a cytoskeletal signaling inhibitor that can be used for its potential to target αvβ6 integrin involved in fibrosis and certain cancers, aiming to prevent integrin-mediated tissue remodeling and tumor progression.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.